\-\ Texto\\:\\ \ \(0\)\
\-\ non\\-contributory\ \(73\)\
\-\ \\â\\€\\¢\\ left\\ cerebellar\\ subacute\\ hematoma\\ with\\ some\\ mass\\ effect\\.\ \(0\)\
\-\ \\â\\€\\¢\\ 4th\\ ventricle\\ minimally\\ compressed\ \(1\)\
\-\ \\â\\€\\¢\\ hemosiderin\\ ring\\ surrounding\\ hematoma\ \(0\)\
\-\ \\â\\€\\¢\\ linear\\/tubular\\ enhancement\ \(0\)\
\-\ \\â\\€\\¢\\ \\"popcorn\\"\\ lesion\\ medial\\ and\\ inferior\\ to\\ hematoma\ \(0\)\
\-\ developmental\\ venous\\ anomaly\\ \\(dva\\)\\ and\\ cavernous\\ malformation\ \(0\)\
\-\ \\â\\€\\¢\\ venous\\ angioma\\ and\\ cavernous\\ angioma\\ \ \(0\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ \\â\\€\\¢\\ primary\\ neoplasm\ \(0\)\
\-\ \\â\\€\\¢\\ amyloid\\ angiopathy\ \(0\)\
\-\ \\â\\€\\¢\\ anticoagulation\\ therapy\ \(0\)\
\-\ 51\\ year\\ old\\ man\\ with\\ acute\\ onset\\ of\\ headache\\ and\\ ataxia\\.\ \(1\)\
\-\ mri\\ obtained\\ as\\ follow\\-up\\ to\\ ct\\ done\\ 3\\ weeks\\ previously\\ when\\ symptoms\\ first\\ developed\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hematoma\\:\\ 0\\.30995983265294125\ \(0\)\
\-\ angioma\\:\\ 0\\.30986118854062683\ \(0\)\
\-\ cavernous\\:\\ 0\\.2560928121882292\ \(0\)\
\-\ venous\\:\\ 0\\.21078253470097463\ \(0\)\
\-\ dva\\:\\ 0\\.18392894443768723\ \(0\)\
\-\ angiopathy\\:\\ 0\\.17921087743097078\ \(0\)\
\-\ popcorn\\:\\ 0\\.17401797647003395\ \(0\)\
\-\ amyloid\\:\\ 0\\.16686916771322682\ \(0\)\
\-\ hemosiderin\\:\\ 0\\.1651433467012312\ \(0\)\
\-\ compressed\\:\\ 0\\.15987466904063388\ \(0\)\
\-\ ataxia\\:\\ 0\\.14333673395714916\ \(0\)\
\-\ 51\\:\\ 0\\.14093575382556947\ \(0\)\
\-\ minimally\\:\\ 0\\.13997125494140375\ \(0\)\
\-\ subacute\\:\\ 0\\.13814383299621233\ \(0\)\
\-\ anticoagulation\\:\\ 0\\.1369935225334026\ \(0\)\
\-\ 4th\\:\\ 0\\.13589217655907648\ \(0\)\
\-\ anomaly\\:\\ 0\\.1350958760554469\ \(0\)\
\-\ developmental\\:\\ 0\\.12765131865737422\ \(0\)\
\-\ ring\\:\\ 0\\.12434328189483317\ \(0\)\
\-\ and\\:\\ 0\\.1220121201306409\ \(0\)\
\-\ cerebellar\\:\\ 0\\.12080167767699555\ \(0\)\
\-\ previously\\:\\ 0\\.11849991914397102\ \(0\)\
\-\ done\\:\\ 0\\.11742152458972403\ \(0\)\
\-\ malformation\\:\\ 0\\.11385076755599506\ \(0\)\
\-\ developed\\:\\ 0\\.10951894241271698\ \(0\)\
\-\ ventricle\\:\\ 0\\.10865786659505823\ \(0\)\
\-\ obtained\\:\\ 0\\.10441463354256211\ \(0\)\
\-\ effect\\:\\ 0\\.10355065354169589\ \(0\)\
\-\ headache\\:\\ 0\\.10176012574127191\ \(0\)\
\-\ neoplasm\\:\\ 0\\.10077014670874952\ \(0\)\
\-\ inferior\\:\\ 0\\.10042556472730496\ \(0\)\
\-\ first\\:\\ 0\\.09961682001836566\ \(0\)\
\-\ surrounding\\:\\ 0\\.09844920582743348\ \(0\)\
\-\ medial\\:\\ 0\\.09608679161125246\ \(0\)\
\-\ onset\\:\\ 0\\.09478840007493856\ \(0\)\
\-\ some\\:\\ 0\\.09287852115787874\ \(0\)\
\-\ primary\\:\\ 0\\.09076788809124069\ \(0\)\
\-\ when\\:\\ 0\\.08916857895712385\ \(0\)\
\-\ weeks\\:\\ 0\\.08846913842101156\ \(0\)\
\-\ enhancement\\:\\ 0\\.08496517453627268\ \(0\)\
\-\ therapy\\:\\ 0\\.08481494059069825\ \(0\)\
\-\ metastatic\\:\\ 0\\.08095996744519288\ \(0\)\
\-\ symptoms\\:\\ 0\\.08076708910300479\ \(0\)\
\-\ acute\\:\\ 0\\.07985458847398443\ \(0\)\
\-\ man\\:\\ 0\\.07814971987434165\ \(0\)\
\-\ mri\\:\\ 0\\.07577293378378076\ \(0\)\
\-\ to\\:\\ 0\\.07380739802926735\ \(0\)\
\-\ lesion\\:\\ 0\\.07077037307216195\ \(0\)\
\-\ disease\\:\\ 0\\.06196393419246599\ \(0\)\
\-\ as\\:\\ 0\\.05930256843411554\ \(0\)\
\-\ with\\:\\ 0\\.05781009927768508\ \(0\)\
\-\ mass\\:\\ 0\\.05638535451494931\ \(0\)\
\-\ ct\\:\\ 0\\.05619878035099654\ \(0\)\
\-\ left\\:\\ 0\\.05035502206444908\ \(0\)\
\-\ year\\:\\ 0\\.045492331300699594\ \(0\)\
\-\ old\\:\\ 0\\.043688385609951884\ \(0\)\
\-\ of\\:\\ 0\\.02888778919168409\ \(0\)\
